Breaking the black box between strategy and execution

Is half your marketing budget feeding a "black box"?

Life sciences companies excel at measuring two aspects: tactical activities and business outcomes. They know how many emails were opened, how many rep visits occurred, and whether sales targets were achieved. However, they struggle to understand the connection between these extremes: the critical middle ground where tactics transform into business impact.

This "black box problem" isn't just a measurement issue. It's a fundamental flaw in how the industry structures KPI frameworks, leading to poor resource allocation, missed optimisation opportunities, and an inability to distinguish between correlation and causation in commercial performance.

Quick Diagnostic: Is Your Dashboard Missing the Middle?

Look at your current commercial dashboard. Can you answer these questions?

• Can you prove which sequence of touchpoints is most effective at shifting HCP perception?

• Do you have a metric for 'engagement quality' beyond clicks and views?

• Can you link a dip in campaign engagement directly to a specific message or channel? If you answered 'no' to any of these, you have a blind spot in the 'missing middle'

The Current Framework Problem

Most life sciences companies organise their KPI frameworks as hierarchical pyramids: Strategic Imperatives at the top, supported by Key Levers (sometimes also called Critical Success Factors), which are activated through Tactics, with all KPIs clustered at the bottom.

This structure creates three critical problems:

1. The Measurement Mismatch: By placing all KPIs at the bottom level, companies mix fundamentally different types of metrics. Long-term strategic indicators, such as market share and sales growth, sit alongside short-term tactical metrics, including email open rates and website visits, creating confusion about what success looks like and when to measure it.

2. The Causation Assumption: This pyramid model falsely implies that if the business result is positive, every tactic must have worked. It prevents you from seeing which specific activities drove success and which were a waste of resources. Moreover, it helps you overlook externalities: elements outside of your control that significantly influence an HCP's prescribing patterns (e.g., patient preferences, payer policies, hospital budgets, shifting market paradigms, etc.).

3. The Missing Middle: Most critically, this framework completely omits the layer where tactics aggregate into meaningful campaign performance. This is the level at which you can actually assess whether your activities have moved people from point A to point B in their thinking and behaviour.

What Companies Measure (And Miss)

Based on our experience, the industry currently measures approximately 70-80% of tactical activities and 50% of strategic outcomes, while barely addressing the campaign effectiveness layer that connects them.

Tactical Metrics (What gets measured well):

• Reach and frequency data

• Email open rates, click-through rates

• Rep visit counts and call completion rates

• Event attendance and engagement scores

• Website traffic and content downloads

• …

→ These metrics answer the question "did we do the activity?" but tell us nothing about its effectiveness or impact.

Strategic Metrics (Partially measured):

• Sales performance and market share

• Brand awareness and perception scores

• Prescription volumes and market penetration

• …

→ These metrics show end results but offer no insight into which activities drove the outcomes.

Campaign Effectiveness (The missing layer):

• Quality and relevance of interactions

• Depth of engagement beyond surface metrics

• Actual attitude and behaviour shifts

• Progressive movement through the customer journey

• Incremental change in intent to prescribe

• …

→ This is where the real insights live and where most companies have a massive blind spot.

The Time Continuum Reality

Different objectives operate on entirely different timeframes, yet current frameworks try to measure them all with the same cadence and approach:

1. Strategic Imperatives (2-5 years): Stable, long-term objectives like "establish market leadership" or "displace the leading competitor." These should be measured using consistent, long-term KPIs that change only in response to major strategic shifts.

2. Key Levers (6 months - 2 years): The specific behavioural shifts needed to achieve strategic imperatives. For example, "differentiate against competitor X in line one treatment" represents the A-to-B change in HCP thinking and prescribing behaviour.

3. Campaigns (2-6 months): Integrated sets of activities designed to achieve specific key lever objectives. This is where the magic happens—where tactical activities combine to create measurable attitude and behaviour change.

4. Tactics (Days to weeks): Individual activities, such as email sends, rep visits, or webinar delivery. These generate immediate operational metrics but require aggregation to become meaningful.

The Solution: "The Strategic Horizontal Flow Model"

Instead of stacking everything vertically, effective frameworks should flow horizontally, with appropriate KPIs attached to each level:

1. Strategic Level KPIs: Long-term metrics that remain stable (market share, sales growth, competitive position). Measured annually or biannually.

2. Key Lever KPIs: Medium-term metrics that track behavioural shifts (intent to prescribe changes, attitude shifts, adoption rates). Measured every 6-12 months.

3. Campaign KPIs: Complex, integrated metrics that demonstrate progressive customer journey movement and quality of engagement. Measured throughout campaign cycles (2-6 months).

4. Tactical KPIs: Operational metrics for immediate optimisation (open rates, attendance, completion rates). Measured in real-time for ongoing adjustments.

Making Campaign KPIs Work

The breakthrough comes from recognising that campaign KPIs aren't just bigger versions of tactical metrics. They're fundamentally different measurements that assess transformation rather than activity.

Effective campaign KPIs answer critical questions:

• Did we reach the right people with sufficient frequency and quality?

• Did our interactions create genuine engagement or just passive consumption?

• Can we demonstrate progressive shifts in attitude toward our desired outcome?

• Are we seeing incremental changes in stated intent or behaviour?

• How does engagement quality correlate with downstream prescription changes?

→ These metrics require combining quantitative reach data with qualitative engagement assessment, tracking the same individuals across multiple touchpoints, and measuring progressive change rather than point-in-time snapshots.

The Optimisation Opportunity

This horizontal framework creates a powerful optimisation engine. When business results fall short, you can trace the performance back through each level:

→ If tactical metrics are positive but campaign KPIs are weak: Your activities reached people, but didn't create meaningful engagement. The message, format, or delivery approach needs refinement.

→ If campaign KPIs are strong but key lever metrics lag: Your activities are working but may need more time, frequency, or broader reach to create sustainable behavioural change.

→ If key lever metrics improve but strategic outcomes don't: External factors (competitive activity, market changes, regulatory shifts) may be offsetting your progress.

This diagnostic capability transforms KPI frameworks from simple scorecards into strategic learning systems.

Implementation for Life Sciences

For pharma companies ready to make this transition:

1. Start with Campaign KPI Design: Before restructuring everything, focus on developing meaningful campaign effectiveness metrics that go beyond vanity metrics to assess the actual progression of the customer journey.

2. Separate Time Horizons: Clearly distinguish between metrics measured annually (strategic), semi-annually (key levers), quarterly (campaigns), and continuously (tactics).

3. Invest in Integration Capability: Campaign KPIs require connecting data across multiple channels and touchpoints. It’s an infrastructure investment that pays dividends in quality of insight.

4. Train for the Transition: Teams accustomed to pyramid thinking need support in understanding how horizontal integration changes accountability and decision-making.

5. Accept Imperfect Control: Acknowledge that you can't control everything that influences outcomes, but you can control and optimise the quality of your customer engagement activities.

The Strategic Payoff

Companies that master this approach gain sustainable competitive advantages: faster identification of what works and what doesn't, more efficient resource allocation, a stronger causal understanding of their commercial activities, and the ability to adapt quickly to changing market conditions without losing strategic focus.

Most importantly, they break free from the black box that has long frustrated commercial teams, finally connecting the dots between daily activities and business outcomes in ways that drive continuous improvement and superior patient outcomes.

The framework isn't just about better measurement. It's about creating the organisational capability to learn, adapt, and execute more effectively in an increasingly complex environment.